RemedyOne

RemedyOne cuts through the complexity of modern pharmaceutical programs to uncover opportunities to grow, to flex agreements in your favor and to help you take decisive action on what matters.

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars

The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be a test for industry stakeholders, as their entrance will reveal whether blockbuster drugs—that offer significant rebates—can be replaced to reduce the cost burden on patients and payers in the United States. Download our …

Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars Read More »

Uncovering Solutions for Affordable Drug Pricing

The House Committee on Oversight and Reform held a series of hearings to review findings from an in-depth investigation into drug pricing actions that was conducted last year with CEOs representing some of the largest and most profitable pharmaceutical manufacturers. As stated in the summary report of the investigation by Chairwoman Carolyn Maloney, “the drug …

Uncovering Solutions for Affordable Drug Pricing Read More »